Johnson & Johnson orthopedic sales in the U.S. and worldwide decreased year over year in the fourth quarter of 2021, according to financial results posted Jan. 25.
Five things to know:
1. Worldwide orthopedics sales in the fourth quarter were $2.2 billion; that's a 1.6 percent decrease from the same time last year. In the U.S., orthopedics sales were down 3.5 percent with $1.3 billion.
2. Hip sales worldwide increased 2.1 percent year over year with quarterly revenue of $380 million. Knees saw $342 million in the fourth quarter, which is down 0.9 percent year over year.
3. Total fourth quarter sales were $24.8 billion, a 10.4 percent increase year over year. For the full year of 2021, Johnson & Johnson reported $93.8 billion in sales, a 13.6 percent increase compared to 2020.
4. The medical devices segment saw a 16.8 percent growth overall. This was largely driven by market recovery from COVID-19.
5. The company expects 2022 sales growth of 7.7 percent.